93 1077
Pill imprint 93 1077 has been identified as Cefprozil 250 mg.
Cefprozil is used in the treatment of sinusitis; bladder infection; upper respiratory tract infection; kidney infections; tonsillitis/pharyngitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefprozil 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefprozil Images
- Imprint:
-
93
1077 - Strength:
- 250 mg
- Color:
- Orange
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
D&C Yellow No. 10
FD&C Red No. 40
FD&C Yellow No. 6
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-1077
More Cefprozil resources
- Cefprozil (Wolters Kluwer)
- Cefprozil Suspension (Wolters Kluwer)
- cefprozil (Cerner Multum)
- cefprozil (Micromedex) - Includes Dosage Information
- Cefprozil (AHFS DI)
- Cefprozil (FDA)
- Cefprozil Tablets (FDA)
- Cefprozil (Wolters Kluwer)


